May 16, 2008 - Phenomix Announces PHX1149 Phase 2B Clinical Trial Results For Type 2 Diabetes

January 25, 2008 - Phenomix Files Registration Statement For Proposed Initial Public Offering

October 15, 2007 - Phenomix Hires John Crawford As Chief Financial Officer and Appoints Arlene Morris to Board of Directors

September 11, 2007 - Phenomix Initiates Phase 2b Clinical Trial Of PHX1149 For Type 2 Diabetes; Will Present PHX1149 Data At EASD

July 19, 2007 - Phenomix Appoints James Harper and William Harris to Board of Directors

March 8, 2007 - Phenomix Completes $55 Million Series C Financing

March 5, 2007 - Phenomix Completes Phase 2A Clinical Trial Diabetes Drug Is Efficacious And Well Tolerated